Friday, July 11, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Banking & Finance

Bayer and Arogya Finance introduce the Eylea Easy Pay Program

Fiinews by Fiinews
December 22, 2020
in Banking & Finance, Health, Technology
Reading Time: 3 mins read
A A
0
Bayer
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Eylea Easy Pay Program for patients

Bayer, a global group with core competencies in the life science fields of health care and nutrition, is collaborating with social healthcare venture Arogya Finance to introduce the Eylea Easy Pay Program in India to provide flexible and affordable payment solutions to help patients in access Eylea (aflibercept solution) treatment.

Bayer and Arogya Finance partnership has increased the accessibility of the innovative treatment solutions, thus reducing the immediate financial burden on patients and their families.

These financing solutions will be available across the country. Centers in states like Maharashtra, Delhi, Karnataka, Bengal, Kerala, Tamil Nadu, Uttar Pradesh, to name a few, will offer this program to their patients, said Bayer.

Today, diabetes affects close to 67 million people in India, and approximately 3-4.5 million of them develop visual impairments due to diabetic eye diseases, such as Diabetic Macular Edema (DME).

Bayer’s Eylea is used for the treatment of both Wet AMD, which affects the elderly population and DME, which affects diabetics, and is administered via an injection directly into the eye. Since Eylea is an ongoing treatment for chronic eye conditions, treatment adherence is important.

Bayer launched the “Eylea 4 U” Patient Assistance Program in 2020 with the objective of improving access and adherence to the treatment by Indian patients. In continuation with this aim, Bayer and Arogya Finance have collaborated to tackle the central issue of patient adherence by reducing the upfront financial burden of treatment that usually impacts the patient and their families.

The benefits of this collaboration include lower up-front payments, flexibility in payment options and easy equated monthly installment (EMI). With treatment accessibility and patient centricity as the key focus, Eylea Easy Pay aims to help patients and caregivers focus on effective management of the condition.

“At Bayer, we have always been committed to a Patient First approach to treatment. We aim to provide effective and innovative solutions to address unmet health needs while supporting our patients in accessing and adhering to their treatment plans,” Manoj Saxena, Managing Director, Bayer Zydus Pharma & Country Division Head South Asia, said on 22 Dec 2020.

“By collaborating with Arogya Finance, we extend our commitment to delivering solutions to improve and maintain vision, to support patients on their journey to better health,” he said announcing the collaboration.

“We at Arogya Finance work to establish an ecosystem which benefits the patients and their caregivers through the ease of financing solutions for treatment,” added Jose Peter, Co-founder and CEO, Arogya Finance.

“Arogya Finance has partnered with Bayer so we can work together to deliver flexible financing solutions that support increased patient access to treatment to enable a greater number of individuals across India to benefit from the innovative therapy,” said Peter.

This program offered by Arogya Finance in collaboration with Bayer will defiantly help patients to maintain good treatment compliance, thus ensuring they can access the best treatment options available, said Dr. Shobhit Chawla, President of Vitreo Retina Society of India (VRSI) and Sr. Vitreo Retina Consultant at Prakash Netra Kendra, Lucknow.

“Such programs enable patients and their caregivers to focus on maintaining health with greater confidence and convenience while reducing the financial burden,” he said.

“There is an urgent need to drive attention towards avoidable vision loss in India. Preventive care, diagnosis and adherence to long term treatment has been impacted during the pandemic,” Dr. Chawla elaborated in comments on the partnership.

“We have observed a drop in patient adherence to treatment for Wet AMD and DME, often due to financial constraints,” he added.

Arogya Finance is a social healthcare venture providing medical loans for medical treatment using a new model for measuring creditworthiness and risk. Launched in 2011, Arogya Finance has partnered with 50 hospitals and healthcare service providers across India and processed 320 loans. #health #technology #banking #diabetics /fiinews.com

Tags: Arogya FinanceBayer
ShareTweetShare

Related Posts

Ansrsource With Tagline
Technology

Tech: ansrsource-ANSR reshape talent across India

by Fiinews
July 11, 2025
0
18

Ahuja to help clients achieve unprecedented levels of operational excellence Austin’s ansrsource has formed a strategic partnership with ANSR, the...

Infogain
Infogain

Tech: Infogain launches GCC solutions in India

by Fiinews
July 11, 2025
0
18

GCC solutions for AI-driven talent, infrastructure and processes Infogain, a leader in digital customer experience engineering based in Silicon Valley,...

Synergy Quantum

Tech: Partners work on India’s first space infra

July 10, 2025
13
PIB

Tech: Every Indian stakeholder in bioeconomy

July 9, 2025
23
Dr Chinmay Hegde

Tech: S!aP Cognus platform launched

July 7, 2025
26
MTI

Tech: TCS to be part of Singapore Smart Nation

July 5, 2025
23
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Project: Japanese delegation inspects DMIC progress
  • Project: Mindset change is critical for innovation
  • Project: 4,000% in installed solar capacity
  • Project: EV policies part of climate goals
  • Tech: ansrsource-ANSR reshape talent across India

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.